Healthcare ❯Pharmaceuticals ❯Weight Loss Medications ❯GLP-1 Receptor Agonists
A slight drop in obesity rates from 46% to 45.6% in 2023 is linked to the growing use of weight-loss drugs like Ozempic and Wegovy.